LANTERNA Receives PATENT From USPTO For FACET MOTION TECHNOLOGY

LANTERNA News >>

LANTERNA RECEIVES PATENT FROM USPTO FOR FACET MOTION TECHNOLOGY

SAINT GALLEN: December 22nd 2015 - Lanterna Medical Technologies GmbH.

Lanterna Medical Technologies, a medical device company focused on developing innovative, intuitive and cost effective solutions for the surgical treatment of human skeletal disease, announced today, that Lanterna has received a notice of allowance from the United States Patent Office granting a key patent protecting the company's technology for the resurfacing of the human facet joint:"FACET IMPLANT Appl. #10/651,871."

Mrs. Kemine Hale, Lanterna's Managing Director commented:

"With the allowance of this new patent, the Patent Office has confirmed Lanterna's innovative position in this fast-paced technological arena. This newest addition to its patent portfolio confirms Lanterna's continuing commitment to innovation and development of industry leading medical device solutions. We will continue to work to expand the Lanterna Spine patent portfolio as we continue to innovate and develop new products."

Mrs. Hale added, "The grant of this patent confirms the uniqueness of the FENIX® Facet Resurfacing family of devices and further strengthens our solid USA and international patent portfolio.

We believe this technology represents the next evolution in the surgical treatment of human spine disease and as such we will be working diligently to bring it to the world."

Back